Related Experiment Video
Updated: May 12, 2026

Selective Depletion of Microglia from Cerebellar Granule Cell Cultures Using L-leucine Methyl Ester
Published on: July 7, 2015
Valproate-Induced Hyperammonemic Encephalopathy Successfully Treated With Levocarnitine in an Elderly Patient Without
Masahiko Kaneko1, Hisaharu Shikata1, Hisafumi Kihara1
1Department of Internal Medicine and Hematology, Uwajima City Hospital, Uwajima, JPN.
Valproate therapy can cause hyperammonemic encephalopathy due to carnitine depletion. Prompt levocarnitine treatment effectively manages this serious side effect in patients with seizure disorders.
Area of Science:
- Neurology
- Clinical Pharmacology
- Biochemistry
Background:
- Valproate is a widely used antiepileptic drug.
- Long-term valproate use can lead to carnitine depletion.
- Carnitine depletion is associated with hyperammonemic encephalopathy.
More Related Videos
08:47Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmaceutical Poisoning: Treatment Strategies
Hepatic Encephalopathy